Get In Touch
We’re eager to hear from you!
AI-Powered Microbiome Intelligence for Human Health
Alphabiome’s groundbreaking technology extracts genetic biomarkers from microbial DNA at an unprecedented scale and precision to predict the efficacy of biological and biochemical treatments.
Cracking the Genetic Code of the Microbiome
The microbiome holds immense untapped potential for predicting drug efficacy. Alphabiome’s revolutionary AI platform deciphers the previously inaccessible 99% of microbial genetic data with groundbreaking accuracy, identifying valuable biomarkers at an unprecedented accuracy, thereby unlocking new possibilities for precision medicine.
Discover Alphabiome
Learn more about how Alphabiome’s groundbreaking technology is opening new frontiers in precision medicine.
Alphabiome’s Unique Approach
Alphabiome’s AI-driven proprietary technology deciphers trillions of genetic data fragments to identify biomarkers that will transform drug development by optimizing personalized treatment selection.
1
Unparalleled Scale
Unparalleled Scale
With over 100,000 biomarkers discovered, we are unlocking unprecedented opportunities for medical breakthroughs.
2
Precision-Driven Insights
Precision-Driven Insights
Leveraging vast genetic datasets, we empower pharmaceutical companies to predict treatment efficacy with greater accuracy – accelerating personalized medicine and improving patient outcomes.
3
Scalable & Market-Ready
Scalable & Market-Ready
Our technology seamlessly adapts across a broad spectrum of drugs and treatments, from blockbuster therapies to repurposed phase 2 candidates – driving diverse revenue streams through licensing, accelerated approvals, and targeted innovation.
Scientific Leadership
Dr. Yaniv Altshuler
Founder & CEO
Prof. Alex “Sandy” Pentland
MIT Professor and AI Pioneer
Prof. Roger Kornberg
Nobel Laureate in Chemistry
Prof. Michael Levitt
Nobel Laureate in Chemistry